[Hypercoagulation and cancer. New treatment possibilities].
Lykke
Jakob
J
H:S Hvidovre Hospital, Gastroenheden, Kirurgisk sektion. jly@dadlnet.dk
Nielsen
Hans Jørgen
HJ
D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D001779:Blood Coagulation Factors / Q000502:physiology; D015942:Factor VIIa / Q000502:physiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D006493:Heparin; D015942:Factor VIIa